Neuroone Med Technologies Co.
13F holders, Q1 2024 (March 31)18holders
$1.20avg. 13F price*
At the end of Q1 2024, 18 institutions reported holding Neuroone Med Technologies Co. in their 13F filings. The largest holders were Nantahala Capital Management, LLC ($1.4M), Vanguard Group Inc. ($1.1M) and Geode Capital Management, LLC ($266K).
- Company
- Neuroone Med Technologies Co.
- CUSIP
- 64130M209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $14K |
| Exits | 3 | $60K |
Ownership 18 holders
| Nantahala Capital Management, LLC | 0.14% | Reduce -1.3% | 1,198,912 | $1.4M |
| Vanguard Group Inc. | 0.00% | Add +0.2% | 919,321 | $1.1M |
| Geode Capital Management, LLC | 0.00% | Add +12.6% | 221,949 | $266K |
| Mayo Clinic | 3.55% | No change | 181,754 | $218K |
| Perkins Capital Management Inc. | 0.15% | No change | 150,000 | $180K |
| State Street Corp. | 0.00% | No change | 51,599 | $62K |
| MAI Capital Management | 0.00% | No change | 50,000 | $60K |
| Northern Trust Corp. | 0.00% | No change | 30,281 | $36K |
| Princeton Global Asset Management LLC | 0.00% | No change | 16,833 | $20K |
| Two Sigma Securities, LLC | 0.00% | New | 11,310 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +36.3% | 7,002 | $8K |
| Centerpoint Advisors, LLC | 0.00% | No change | 5,000 | $6K |
| Simplex Trading, LLC | 0.00% | Reduce -41.1% | 1,720 | $2K |
| Nemes Rush Group LLC | 0.00% | No change | 433 | $520 |
| Osaic Holdings, Inc. | 0.00% | No change | 350 | $420 |
| Wells Fargo & Company | 0.00% | Add +10.3% | 193 | $232 |
| UBS Group AG | 0.00% | Reduce -94.3% | 108 | $130 |
| JPMorgan Chase & Co. | 0.00% | Add +41.0% | 55 | $66 |
"% of holder's portfolio" is NEUROONE MED TECHNOLOGIES CO's weight in each manager's 13F, not the share of Neuroone Med Technologies Co. the manager owns.